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 Abstract 
 An array of substrates link the tryptic serine protease, 
kallikrein-related peptidase 14 (KLK14), to physiological 
functions including desquamation and activation of signal-
ing molecules associated with infl ammation and cancer. 
Recognition of protease cleavage sequences is driven by 
complementarity between exposed substrate motifs and the 
physicochemical signature of an enzyme ’ s active site cleft. 
However, conventional substrate screening methods have 
generated confl icting subsite profi les for KLK14. This study 
utilizes a recently developed screening technique, the sparse 
matrix library, to identify fi ve novel high-effi ciency sequences 
for KLK14. The optimal sequence, YASR, was cleaved with 
higher effi ciency ( k 
cat / K M = 3.81 ± 0.4 × 10 6  m -1 s -1 ) than favored 
substrates from positional scanning and phage display by 
2- and 10-fold, respectively. Binding site cooperativity was 
prominent among preferred sequences, which enabled optimal 
interaction at all subsites as indicated by predictive modeling 
of KLK14/substrate complexes. These simulations constitute 
the fi rst molecular dynamics analysis of KLK14 and offer a 
structural rationale for the divergent subsite preferences evi-
dent between KLK14 and closely related KLKs, KLK4 and 
KLK5. Collectively, these fi ndings highlight the importance 
of binding site cooperativity in protease substrate recognition, 
which has implications for discovery of optimal substrates 
and engineering highly effective protease inhibitors. 
 Keywords:  phage display;  positional scanning synthetic 
combinatorial library;  serine protease;  sparse matrix library; 
 substrate specifi city. 
 Introduction 
 The discovery of an expanded human kallikrein-related 
peptidase (KLK) locus containing 15 homologous (chymo)
trypsin-like serine proteases (Clements et al. , 2001 ; Yousef 
and Diamandis , 2001 ) transformed perceived associations 
between this family of enzymes and human (patho)physi-
ology (Borgono and Diamandis , 2004 ; Clements et al. , 
2004 ; Hollenberg et al. , 2008 ; Sotiropoulou et al. , 2009 ). 
Potential functions both in homeostasis and disease have 
now emerged for many of the newly identifi ed KLKs across 
a wide range of tissues including the prostate (Takayama 
et al. , 2001 ; Michael et al. , 2006 ), skin (Brattsand et al. , 2005 ; 
Deraison et al. , 2007 ), and central nervous system (Shimizu 
et al. , 1998 ; Scarisbrick et al. , 2002 ). The recent isolation of 
active KLK14 in extracts of human skin by Stefansson et al. 
 (2006) prompted suggestions that KLK14 formed part of the 
protease cascade responsible for maintaining the epidermal 
barrier (Brattsand et al. , 2005 ; Deraison et al. , 2007 ). This 
view was strengthened by tissue expression profi ling, which 
revealed that KLK14 was most abundant in the skin, with 
comparatively lower levels in steroid hormone-sensitive tis-
sues including the breast and prostate (Borgono et al. , 2007b ). 
Known substrates for KLK14 have prominent functions in 
several of these tissues and include the extracellular cadherin 
link in mature desmosomes, desmoglein 1 (Fortugno et al. , 
2011 ), two members of the protease-activated receptor (PAR) 
family (PAR2 and PAR4) (Oikonomopoulou et al. , 2006 ), 
and a plethora of extracellular matrix proteins (Borgono 
et al. , 2007b ). 
 The physiological importance of these substrates empha-
sizes the need for KLK14 proteolysis to be appropriately 
controlled. Aberrant KLK14 proteolytic activity is linked 
to several skin pathologies by promoting premature prote-
olysis of desmoglein 1 and prolonged stimulation of proin-
fl ammatory signaling pathways including PAR2 (Stefansson 
et al. , 2008 ; Cork et al. , 2009 ). PAR2 activation by KLK14 
has also attracted recent interest in colon cancer where 
KLK14 is more highly expressed than in healthy tissue 
and signaling via PAR2 has been shown to stimulate pro-
liferation of colon cancer cells  in vitro (Gratio et al. , 2011 ). 
Additionally, overexpression of KLK14 has been detected 
in several hormone-dependent cancers, including prostate 
(Yousef et al. , 2003 ; Rabien et al. , 2008 ), ovarian (Borgono 
et al. , 2003 ), and breast (Borgono et al. , 2003 ; Fritzsche 
et al. , 2006 ), correlating with higher risk of disease progres-
sion. Collectively, these observations suggest KLK14 is a 
potential point of therapeutic intervention in a variety of 
pathologies. However, as protease mediated biological func-
tions are often coordinated by complex interactions with a 
larger protease network, the relevance of KLK14 proteolytic 
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activity, both in the skin and in cancer progression, remains 
to be completely understood. 
 Recognition of protease cleavage sequences is driven 
by topological and chemical complementarities between 
a substrate and the enzyme active site. These interactions 
are fundamental to the biological function(s) of a protease 
and, in essence, can be recapitulated by screening libraries 
of shorter model sequences. Accordingly, substrate specifi -
city analyses form a common component in strategies 
aimed at engineering highly potent and specifi c protease 
inhibitors (Goettig et al. , 2010 ; Swedberg et al. , 2010 ) for 
further development as therapeutics or research tools such 
as activity-based probes. High-throughput screening can 
also be used to predict novel substrates and deconvolute 
sequential processing events. These strategies have been 
applied to many of the newly identifi ed KLKs (Matsumura 
et al. , 2005 ; Debela et al. , 2006b ; Borgono et al. , 2007a ), 
including KLK14, which has been screened by phage dis-
play (Felber et al. , 2005 ) and a positional scanning synthetic 
combinatorial library (PS-SCL) (Borgono et al. , 2007a ). 
However, the predicted optimal KLK14 substrates from 
these studies do not accord and highly divergent sequences 
VGSLR (Felber et al. , 2005 ) and YAAR (Borgono et al. , 
2007a ) were identifi ed. This lack of agreement refl ects 
weaknesses in both techniques. In phage display, the vari-
able sequence can modulate biosynthesis effi ciency and 
infectivity, leading to positive and negative selection inde-
pendent of phage cleavage by the target protease (Wilson 
and Finlay , 1998 ). These sources of bias are overcome by 
positional scanning where library diversity is generated by 
synthetic chemistry, but the method is unable to identify 
cooperativity effects, as binding sites are screened inde-
pendently (Ng et al. , 2009 ; Schneider and Craik , 2009 ; 
Swedberg et al. , 2010 ), and library complexity prevents 
conclusive validation of its composition. Taken together, 
these suggested that the substrate specifi city of KLK14 
was yet to be completely described. 
 Incomplete knowledge of a target protease ’ s substrate 
specifi city is a major obstacle to achieving optimal potency 
and selectivity for engineered inhibitors. Recent studies on 
KLK4 (Swedberg et al. , 2009 ) and plasmin (Swedberg and 
Harris , 2011 ) have overcome this challenge by coupling 
PS-SCL with a sparse matrix substrate screen to discover 
previously unrecognized high-effi ciency peptide substrates. 
This technique builds on existing binding site preferences 
by producing a second peptide library where all sequence 
combinations based on known favored residues are indi-
vidually synthesized and analyzed. Here we report the use 
of PS-SCL analysis followed by a sparse matrix substrate 
screen to elucidate a new tetrapeptide substrate profi le for 
KLK14, which was subsequently dissected at the structural 
level using molecular modeling. These fi ndings add further 
support to the emerging appreciation of subsite coopera-
tivity in substrate recognition (Ng et al. , 2009 ; Swedberg 
et al. , 2009 ; Swedberg and Harris , 2011 ), which has previ-
ously proven vital for engineered inhibitors achieving opti-
mal effi cacy (Swedberg et al. , 2009, 2011 ; Swedberg and 
Harris , 2011 ). 
 Results 
 Separate combinatorial analyses do not yield 
a defi nitive specifi city profi le for KLK14 
 As specifi city profi les from PS-SCL have shown variabi-
lity when the same protease is analyzed by independently 
produced libraries (Matsumura et al. , 2005 ; Debela et al. , 
2006b ; Borgono et al. , 2007a ), KLK14 was screened 
against a second P1-P4 diverse library (including all natu-
rally occurring amino acids) with a  para -nitroanilide (pNA) 
reporter group (Figure  1 ). A clear preference for Arg at P1 
was observed, although cleavage rates for other residues 
were higher than previously reported. At P2, Ser was 
highly favored followed by Val, Asn, and Pro, indicating 
small polar or hydrophobic residues were tolerated at this 
position, whereas larger residues (Gln, Tyr, and Trp) were 
strongly disfavored. Small hydrophobic residues such as 
Val, Leu, and Ala were preferred at P3 as opposed to acidic 
or aromatic residues, whereas KLK14 displayed an equiva-
lent preference for Tyr and Trp at P4. The newly generated 
specifi city profi les were noticeably different from the previ-
ous KLK14 PS-SCL screen, which had indicated Ala, Asn, 
and Pro were more favored than Ser at P2; Lys and Ala 
were the most preferred residues at P3, while Tyr was sug-
gested to be clearly favored over Trp at P4. The lack of con-
cordance between the two screens is a likely consequence 
of differing library composition, as distinct methods were 
used to generate library diversity. 
 Non-combinatorial library screen reveals 
subsite cooperativity 
 To identify individual cleavage sequences, a non-
combinatorial sparse matrix library was produced and 
screened against KLK14 (Figure  2 ). Across all substrates, 
sequences containing Ala at P3 were hydrolyzed at the high-
est rates, Tyr and Trp appeared to be similarly preferred at 
P4, while sequences containing Ser at P2 were generally 
favored, although two substrates cleaved at high rates con-
tained Val at this position. Four sequences were noticeably 
preferred by KLK14 and cleaved with substantially higher 
rates than the remainder of the library: YAVR, WAVR, YASR, 
and WASR. Additionally, several instances of subsite coop-
erativity were evident that could not have been identifi ed 
following a combinatorial peptide library screen. Within 
the substrate sets analyzed, Val at the P3 site always 
resulted in a P4 preference for Trp as opposed to Tyr when 
Ala or Leu occupied P3. Furthermore, substrates with the 
same P4-P3 pairing were cleaved at equivalent rates in the 
P2 Val and P2 Asn sublibraries, apart from Tyr-Ala and 
Trp-Ala, which were cleaved with twice the rate when Val 
was present at P2. Indeed, these two sequences (YAVR and 
WAVR) showed the highest cleavage rates from the entire 
library screen, highlighting the need to consider subsite 
cooperativity when prospecting for highly favored pro-
tease substrates. 
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 Kinetic constants confi rm cooperativity trends 
and identify optimal catalytic effi ciencies for sparse 
matrix substrates 
 Determining kinetic constants for KLK14 cleavage of 
favored substrates confi rmed the subsite cooperativity 
trends initially apparent from single concentration rates 
(see Figure 2). The preferred residue at P4 was shown to 
be dependent on the adjacent residue at P3. Consistent with 
P3 Ala producing a clear preference for Tyr over Trp at P4, 
YASR was cleaved with 1.33-fold higher  k 
cat and 2.02-fold 
higher  k 
cat / K M than WASR. The opposite effect was seen 
with P3 Val, which changed the P4 preference to Trp and 
WVSR was cleaved with 1.25-fold higher  k 
cat and margin-
ally higher  k 
cat / K M than YVSR. There was also evidence 
for P4-P2 cooperativity. For substrates containing P3 Ala, 
replacing Val with Ser at P2 produced an 87 % increase in 
 k 
cat / K M when substrates contained P4 Tyr (YAVR vs. YASR), 
while the same substitution with Trp at P4 had essentially 
no effect (WAVR vs. WASR). When compared to sequences 
identifi ed by conventional methods, all fi ve sparse matrix 
substrates were cleaved with higher catalytic effi ciency 
( k 
cat / K M ) than all substrates suggested to be highly preferred 
by combinatorial peptide libraries, YAAR (Borgono et al. , 
2007a ) and WVSR, or phage display, VGSLR (Felber et al. , 
2005 ). Additionally, the substrates hydrolyzed at the highest 
rate in the sparse matrix screen (YAVR and WAVR) were 
cleaved with higher  k 
cat values than all substrates identifi ed 
by existing specifi city screens. 
 Molecular modeling of preferred KLK14 substrates 
 Predictive modeling was undertaken to explore the differ-
ent protease/substrate interactions formed by selected opti-
mal substrates (YASR: highest  k 
cat / K M ; WAVR: highest  k cat ) 
and substrates from PS-SCL and phage display. Molecular 
dynamics (MD) simulations were performed for each pep-
tide-pNA in complex with a homology model of KLK14 (see 
Methods) followed by calculation of the average structure 
(Figure  3 ). These analyses indicated that only the substrates 
from the sparse matrix library screen (YASR and WAVR) 
formed highly favored interactions at all KLK14 subsites. For 
YASR (Figure 3A), both P2 Ser and P4 Tyr formed hydro-
gen bonds with the protease (with His99 and Arg97, respec-
tively, trypsin numbering), whereas Ala was well suited to 
the small S3 pocket. Tyr at P4 also participated in an aro-
matic  π -stacking interaction with Trp215. In contrast, WAVR 
(Figure 3B) relied on favorable nonpolar interactions across 
the S4-S2 sites with Val binding within the narrow S2 pocket 
and Trp accommodated by the large S4 pocket. 
 Many of these features were also evident in the substrates 
identifi ed by positional scanning, yet each sequence suffered 
from poor complementarity at some point along its length. 
For YAAR (Figure 3C), the S2 pocket was capable of accept-
ing residues larger than Ala, which did not seem to interact 
with the protease (Figure 3F); for example, replacing P2 Ala 
with Val or Ser produced substantial improvements in both 
 k 
cat and  k cat / K M (Table  1 ). Conversely, while WVSR (Figure 
3D) contained the highly favored Ser at P2, Val was too bulky 
 Figure 1  KLK14 positional scanning analysis using a P1-P4 diverse combinatorial peptide-pNA library. 
 Twenty peptide pools were produced for each nonprimed (P) binding site screen, which consisted of tetrapeptide substrates with one of the 
naturally occurring amino acids fi xed at the position indicated above each graph. The fi xed residue is shown on the  x -axis in single-letter amino 
acid code with M* being methionine sulfone, while remaining binding sites contain a mixture of residues. Protease activity was detected by 
release of the pNA reporter [measured by increasing absorbance mOD 405 nm per min] and is expressed as a proportion of the highest rate 
within each sublibrary. Data are shown as mean ± SEM from three independent experiments performed in triplicate. 
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for the S3 pocket resulting in loss of a backbone-backbone 
hydrogen bond with KLK14 (Gly216). This was consistent 
with the reduction in  k 
cat and  k cat / K M (32 % and 25 % , respec-
tively) observed when Val occupied P3 compared with Ala 
(WASR vs. WVSR, Table 1). These residues may be more 
favored with different sequence combinations, which would 
justify their general preference in positional scanning yet 
not as part of the individual substrates cleaved with highest 
effi ciency. 
 Nonetheless, the substrates from PS-SCL and the sparse 
matrix library were all cleaved with a least 10-fold higher 
catalytic effi ciency than the optimal substrate identifi ed by 
phage display (VGSLR; Figure 3E). This was in agreement 
with the MD average structure, which revealed that while 
P2 Leu seemed to be well-tolerated, neither the P3 nor P4 
residues appeared to make favorable contacts with KLK14. 
The Ser (P3) side-chain did not form any hydrogen bonds 
with KLK14 and was in fact oriented away from the protease 
(Figure 3E, F). Additionally, P4 Gly seemed preferred simply 
to fulfi ll a spacing requirement allowing Val to interact with 
the same hydrophobic determinants as aromatic P4 residues, 
particularly Trp (Figure 3E, F). Consistent with this, KLK14 
cleavage of a tetrapeptide sequence lacking Val (GSLR com-
pared with VGSLR) yielded lower  k 
cat and  k cat / K M values by 
3- and 4-fold, respectively (Table 1). 
 Structural comparison of KLK14 with the closely 
related KLK4 and KLK5 
 One of the hallmarks of the KLK family is a high degree of 
sequence similarity across the active site cleft (Goettig et al. , 
2010 ; Swedberg et al. , 2010 ), yet unique substrate specifi c-
ity profi les have been found for all KLKs screened to date 
(Debela et al. , 2006b ; Borgono et al. , 2007a ). KLK14 is par-
ticularly homologous to KLK4 and KLK5, both in terms of 
backbone conformation (average C α RMSD between KLK14 
and KLK4, 0.77  Å , or KLK5, 0.39  Å ; Figure  4 A) and sequence 
homology at the active site, including the S1-S4 binding sites 
(Figure 4B). However, several regions of sequence divergence 
were evident (Figure 4C), which seemed to justify differences 
between the newly identifi ed KLK14 sequences and existing 
subsite preferences for KLK4 and KLK5 (summarized in 
Table  2 ), particularly at the S2 and S4 subsites. 
 His99 fl anks the S2 pocket of both KLK5 and KLK14, 
and accordingly, preferences at this subsite overlap consider-
ably (Ser being the most preferred while Asn is also favored). 
However, structural overlay suggested His99 for KLK5 was 
oriented slightly further outward from the protease, increas-
ing the width of the S2 pocket. This would potentially 
explain the KLK5 preference for Phe or His while KLK14 
favors the smaller side-chain of Val. For KLK4, the same 
region is occupied by Leu99, hence Val is favored but not 
Ser or Asn, as the protease lacks a nearby hydrogen bonding 
residue. The orientation of Leu99 also broadens the entrance 
to the S2 subsite, enabling P2 Gln to access hydrogen bonds 
with the side-chains of Asp102 and Ser214 (Debela et al. , 
2006a ), making Gln the most preferred residue for KLK4 at 
this site. 
 KLK5 and KLK14 also show a high degree of similar-
ity within the S4 site with Trp215 present in both enzymes 
compared with Phe215 for KLK4. However, KLK14 shows 
an equivalent preference for Tyr and Trp at P4 while KLK5 
favors Tyr. This could be due to differences at position 175 
as Thr175 (KLK14) does not extend as far into the pocket as 
Gln175 (KLK5), hence KLK14 is better suited to accommo-
date Trp at P4. Preferences at the KLK4 S4 site are markedly 
different with smaller, hydrophobic P4 residues (Phe and Ile) 
highly favored as opposed to Tyr and Trp. This is likely to be 
a combined result of two factors. First, the kallikrein ( ‘ 99 ’ ) 
 Figure 2  Non-combinatorial library screen defi nes the extended substrate specifi city of KLK14 in greater depth and identifi es cooperativity. 
 Sparse matrix substrate screen of individually synthesized peptides based on all combinations of known KLK14 binding site preferences. The 
P1 residue was kept constant (Arg), while the P4-P2 residues were varied and the sequence for each substrate (P4, P3, P2, P1) is shown on the 
 x -axis (M* represents methionine sulfone). Hydrolysis was measured in the change in mOD 405 nm per min, and data are expressed as mean ± SEM 
from three independent experiments performed in triplicate. 
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 Table 1  Michaelis ( K M ) and rate ( k cat ) constants for preferred sparse matrix library (SML) substrates compared with positional scanning 
(PS-SCL) and phage display (PD) sequences .
Sequence Screen method Theoretical mass Actual mass  K M ( μ m )  k cat (s -1 )  k cat / K M ( × 10 4 M -1 s -1 )
Ac-YASR-pNA SML 657.78 658.87 22.03 ± 1.44 83.85 ± 1.15 380.6 ± 44.6
Ac-YAVR-pNA SML 669.83 670.93 45.01 ± 2.48 93.33 ± 1.38 207.4 ± 26.1
Ac-WASR-pNA SML 680.82 681.63 33.64 ± 1.04 63.24 ± 0.51 188.0 ± 11.2
Ac-WAVR-pNA SML 692.87 693.81  51.54 ± 1.55 97.31 ± 0.82 188.8 ± 11.0
Ac-YANR-pNA SML 684.80 685.77  16.78 ± 0.98 53.04 ± 0.58 316.1 ± 33.4
Ac-WVSR-pNA PS-SCL 708.87 709.74  30.48 ± 1.63 42.91 ± 0.54 140.8 ± 13.9
Ac-YVSR-pNA PS-SCL 685.83 686.88  25.23 ± 1.56 34.57 ± 0.47 137.0 ± 15.3
Ac-YAAR-pNA PS-SCL 641.78 642.64  43.20 ± 1.39 69.37 ± 0.59 160.9 ± 10.0
Ac-VGSLR-pNA PD 692.87 693.68 318.4 ± 22.3 44.03 ± 1.51   13.83 ± 1.93
Ac-GSLR-pNA PD 593.73 594.58 431.4 ± 19.8 15.80 ± 0.39   3.66 ± 0.35
 Figure 3  Molecular modeling of KLK14/substrate complexes. 
 Average structures from MD simulation of KLK14 (homology model, shown as ribbon plot) in complex with the following peptide-
pNA substrates (shown as green stick model): (A) Ac-YASR-pNA, (B) Ac-WAVR-pNA, (C) Ac-YAAR-pNA, (D) Ac-WVSR-pNA, and 
(E) Ac-VGSLR-pNA. KLK14 residues forming interactions with the peptide ligand are shown in gray stick model and hydrogen bonds are 
shown in purple dashed lines. Residues are labeled in single letter amino acid code with the serine protease catalytic triad indicated by an aster-
isk (*). (F) Overlay of the fi ve peptide substrates (YASR: green, WAVR: magenta, YAAR: gray, WVSR: orange, VGSLR: blue) bound to the 
active site of KLK14 (shown as molecular surface colored according to electrostatic potential: red indicates negative, blue indicates positive). 
The substrate binding sites S4-S1 ′ are indicated. 
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 Figure 4  Structural comparison of KLK14 and closely related KLKs (KLK4 and KLK5). (A) Ribbon plot of the KLK14 homology model 
(yellow) superimposed on the structures of KLK4 (green, PDB ID: 2BDG) and KLK5 (pink, PDB ID: 2PSX). Variable residues around the 
active site are shown in stick model along with the catalytic triad (*). Residues are labeled with single letter amino acid code in the order KLK4/
KLK5/KLK14 using trypsin numbering. (B) Molecular surface of the KLK14 homology model color coded according to sequence conserva-
tion among KLK4, KLK5, and KLK14 (green for identical residues, yellow for conservative sequence variation and red for nonconservative 
sequence variation). The substrate binding sites S4-S1 ′ are labeled. Structural orientation between (A) and (B) is identical. (C) Sequence align-
ment of KLK4, KLK5, and KLK14 with identical residues and conservative substitutions indicated below with an asterisk (*) or period (.), 
respectively. Residues are colored according to side-chain properties (red: acidic, blue: basic, green: polar, black: hydrophobic). Additionally, 
residues within 5  Å of a tetrapeptide substrate bound to the S4-S1 protease binding sites are shaded gray. 
loop in KLK4 is further removed, which leaves fewer hydro-
gen bonding opportunities for Tyr within the S4 pocket unlike 
KLK14 (Figure 3A, C) or KLK5. Second, the proximity of 
Phe215 and Leu175 places a size restriction on favored P4 
residues; hence, Trp is not easily accommodated. 
 Discussion 
 The repertoire of biological functions under the control of 
KLK proteases is highly diverse and to date includes blood 
pressure homeostasis, initiation of infl ammation in several 
tissues, seminogelin hydrolysis, corneocyte turnover in the 
epidermis, enamel matrix degradation, and maintaining cen-
tral nervous system plasticity (see Sotiropoulou et al. , 2009 ; 
Goettig et al. , 2010 , for recent reviews). The involvement of 
one or more KLKs in numerous, unrelated physiological pro-
cesses refl ects the requirement for individual members of the 
KLK family to recognize distinct cleavage sequences in spite 
of high levels of sequence and structural conservation. Unique 
features within the active site cleft are likely to be important 
for directing separate KLKs to accomplish different tasks, 
particularly in cases of overlapping tissue expression profi les, 
highlighting how knowledge of favored protease cleavage 
sequences can interface with structural information to aid 
understanding of a target enzyme ’ s biological function(s). 
 Screening KLK14 against a tailored sparse matrix sub-
strate library identifi ed several highly preferred cleavage 
sequences that were not predicted by previous positional 
scanning and phage display analyses. Moreover, analyz-
ing hydrolysis of individual substrates enabled the substrate 
specifi city of KLK14 to be examined in greater depth, which 
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 Table 2  Substrate specifi city analyses for KLK4 and KLK5. 
P4 P3 P2 P1 Reference
Sparse matrix library preferences
 KLK4 F, I, V V, Q, T Q, V, L   R Swedberg et al. , 2009 
PS-SCL preferences
 KLK4 I, V, Y V, Q, M Q, V, L R, K Debela et al. , 2006b 
 KLK4 I, V, Y Q, S, V Q, V, L R, K Matsumura et al. , 2005 
 KLK4 I, V, F S, Q, A Q, L, V   R Borgono et al. , 2007a 
 KLK5 G, Y, V M, Y, K S, N, T   R Debela et al. , 2006b 
 KLK5 Y, G, V R, K, Y F, N, S   R Borgono et al. , 2007a 
Substrate  k 
cat (s -1 )  K M ( μ m )  k cat / K M ( m -1 s -1 )
Kinetic constants for individual substrates
 KLK4 FVQR-pNA 15.7 679.9 2.31 × 10 4 Swedberg et al. , 2009 
 KLK4 IVQR-pNA  2.10 183.1 1.15 × 10 4 Swedberg et al. , 2009 
 KLK4 Bz-FVR-pNA  1.89  42.5 4.15 × 10 4 Swedberg et al. , 2009 
 KLK5 Boc-VPR-AMC  3.28 200 1.64 × 10 4 Michael et al. , 2006 
 KLK5 Boc-FSR-AMC  2.83 190 1.49 × 10 4 Michael et al. , 2006 
 Preferences from sparse matrix library and PS-SCL screens are shown in single-letter amino acid code and in descending order from left 
(most preferred) to right. 
in turn revealed prominent effects of binding site coopera-
tivity. KLK14 preferences at several subsites were found to 
be dependent on the neighboring sequence, which allowed 
residues that seemed only modestly preferred to become 
highly favored under certain conditions. This was particu-
larly evident in substrates containing Val at the P2 site, which 
were only highly preferred when Trp-Ala or Tyr-Ala occu-
pied P4-P3. These two substrates (WAVR and YAVR) were 
cleaved with higher  k 
cat values than all other substrates exam-
ined. Conversely, since the biological activity of each KLK14 
subsite was not autonomous, the substrates based on the most 
preferred residue at each binding site from separate PS-SCL 
screens were not cleaved with optimal effi ciency. This was 
supported by predictive modeling of KLK14/substrate com-
plexes, which indicated that in these sequence combinations, 
interaction with at least one protease binding site was not 
optimal. In contrast, the substrates identifi ed by the sparse 
matrix substrate screen were cleaved with higher effi ciency 
and formed highly favored interactions at all binding sites. 
 Extending molecular modeling analyses to related KLKs 
enabled known specifi city differences among KLK4, KLK5, 
and KLK14 to be explored. Subtle active site differences were 
identifi ed for each KLK, which were consistent with highly 
dissimilar optimal cleavage sequences for KLK14 and KLK4: 
YASR (Table 1) and FVQR (Swedberg et al. , 2009 ), respec-
tively. The signifi cance of each KLK active site possessing a 
unique physicochemical fi ngerprint extends to recognition 
of endogenous substrates and inhibitors. For example, the 
P4-P1 residues of the skin-expressed, single-domain Kazal 
inhibitor SPINK6 (YCTR) are strikingly similar to the opti-
mal substrate for KLK14 (YASR) and complementary to the 
PS-SCL profi le for KLK5 but not KLK4. Consistent with this, 
SPINK6 is a more effective inhibitor of KLK5 and KLK14 by 
20- and 60-fold compared with KLK4 (Meyer -Hoffert et al., 
2010 ; Kantyka et al. , 2011 ). Knowledge of highly preferred 
substrates can also be harnessed to design engineered inhibi-
tors with optimal potency and selectivity. Substituting the most 
preferred substrate for KLK4 into the contact surface of sun-
fl ower trypsin inhibitor produced a variant highly selective for 
KLK4 over KLK5 and KLK14 (Swedberg et al. , 2009, 2011 ). 
A similar approach enabled the production of high-affi nity pep-
tide aldehyde inhibitors for plasmin, which displayed selectiv-
ity over plasma kallikrein (Swedberg and Harris , 2011 ). 
 The affi nity and selectivity of these engineered inhibitors 
further illustrate the merit in considering ligands as a single 
entity rather than the sum of separate binding interactions as 
proposed by combinatorial chemistry. The optimal substrate 
for plasmin was identifi ed by screening a non-combinatorial 
library (Swedberg and Harris , 2011 ) and outperformed the 
divergent sequences found by separate PS-SCL analyses 
(Backes et al. , 2000 ; Harris et al. , 2000 ). Similarly, three inde-
pendent PS-SCL screens for KLK4 (Matsumura et al. , 2005 ; 
Debela et al. , 2006b ; Borgono et al. , 2007a ) predicted different 
substrates that were all cleaved at lower rates than a sequence 
discovered by a sparse matrix library screen (Swedberg 
et al. , 2009 ). In this study, YASR was found to be the optimal 
substrate for KLK14 (Table 1), not YAAR (Borgono et al. , 
2007a ) or WVSR (Figure 1) from separate PS-SCL screens. 
Combinatorial methods such as PS-SCL enable rapid, high-
throughput analysis and have been widely used to establish 
distinct specifi city profi les among members of the kallikrein-
related peptidase (Debela et al. , 2006b ), caspase (Thornberry 
et al. , 1997 ), cathepsin (Choe et al. , 2006 ), and plasmepsin 
(Beyer et al. , 2005 ) protease families. However, positional 
scanning has equally been unable to conclusively resolve the 
substrate specifi city of numerous protease targets (see above) 
and the method ’ s shortcomings are not widely appreciated. 
 Paradoxically, the combinatorial nature of the library is the 
most notable drawback of PS-SCL: while it confers practical 
advantages in terms of library synthesis and screening, its use 
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entails a compromise in that only the identity of the fi xed resi-
due is known within each substrate pool. Consequently, the 
neighboring sequence, which can strongly infl uence subsite 
preferences, is largely unknown, preventing identifi cation of 
cooperativity effects (Schneider and Craik , 2009 ; Swedberg 
et al. , 2010 ). This limitation is potentially compounded by 
variable composition within positional scanning libraries. 
The common contention that PS-SCL contains all theoretical 
sequence combinations in equimolar concentrations (Harris et 
al. , 2000 ; Matsumura et al. , 2005 ; Borgono et al. , 2007a ) due 
to the use of isokinetic amino acid mixtures (Ostresh et al. , 
1994 ) is in confl ict with a comprehensive study by Boutin et 
al.  (1997) , which did not fi nd chemical compensation effective 
during competitive dipeptide couplings. Additionally, more 
than 25 % of theoretical sequences could not be detected in the 
fi nal peptide mixture by tandem LC/MS when the experiment 
was expanded to tripeptide and tetrapeptide libraries. 
 Even with these shortcomings, there can be no doubt 
that PS-SCL provides useful information as seen by the 
wealth of existing studies where unique subsite preferences 
were discerned even between closely homologous pro-
teases (Thornberry et al. , 1997 ; Harris et al. , 2000 ; Choe et 
al. , 2006 ; Debela et al. , 2006b ). Indeed, both PS-SCL sub-
strates for KLK14 were cleaved with 10-fold higher effi -
ciency than the best sequence from phage display. Rather, 
this and related studies (Takeuchi et al. , 2000 ; Swedberg et 
al. , 2009 ; Swedberg and Harris , 2011 ) highlight that PS-SCL 
data should be interpreted within the limitations of the 
method ’ s capabilities. Combinatorial peptide library screens 
have proven very effective for identifying individual sub-
site preferences for numerous proteases. However, the abil-
ity of PS-SCL to determine optimal tetrapeptide substrates 
can be compromised by binding site cooperativity effects 
and whether preferred residues are compatible in combi-
nation. These challenges can be overcome by secondary 
screening techniques (Schneider and Craik , 2009 ; Swedberg 
et al. , 2010 ), such as a non-combinatorial sparse matrix library 
(Swedberg et al. , 2009 ; Swedberg and Harris , 2011 ), or high-
throughput proteomic approaches, which enable simultane-
ous analysis of prime and nonprime specifi cities (Schilling 
and Overall , 2008 ). 
 Additionally, the fi ndings from this study add further 
support to the emerging signifi cance of subsite cooperativ-
ity in protease substrate specifi city (see Ng et al. , 2009 , for 
a review). Conditional preferences defi ned by cooperativity 
effects may contribute to the fi ne-tuning that enables indi-
vidual proteolytic enzymes to discern unique cleavage sites 
from a predominating background of nontarget sequences. 
Appreciably, proteolysis of large protein substrates is consid-
erably more complex, and there are additional requirements 
for favorable structural context and complementary interac-
tions beyond the active site. However, cooperativity is likely 
to be particularly relevant to optimal potency and selectiv-
ity of engineered peptide-based inhibitors where the contact 
interface is considerably smaller. Given the result from a 
large-scale specifi city analysis of 13 serine proteases and 11 
cysteine proteases, which revealed sequence-dependent bind-
ing site preferences in all enzymes screened (Gosalia et al. , 
2005 ), the prevalence of subsite cooperativity effects may be 
considerably greater than is currently recognized. 
 Materials and methods 
 Reagents 
 All synthesis reagents were obtained from Auspep (Melbourne, 
Australia) and all solvents from Merck (Melbourne, Australia) un-
less stated otherwise. Thermolysin was obtained from R&D Systems 
(Minneapolis, MN). 
 Production of recombinant KLK14 
 KLK14 was produced in stably transfected Sf9 insect cells 
containing the pro-KLK14 open-reading frame inserted into the 
pIB/V5-His vector Invitrogen (Melbourne, Australia) (Swedberg et al. , 
2009 ). After dialysis, pro-KLK14 was purifi ed from conditioned super-
natant by Ni-NTA superfl ow agarose (Qiagen, Melbourne, Australia) 
according to the manufacturer ’ s instructions. Expression and purity 
were confi rmed by Western blot analysis (against the poly-His epitope) 
and Coomassie-stained SDS-PAGE, respectively. Pro-KLK14 was 
activated with thermolysin at 37 ° C also resulting in the removal of the 
C-terminal tag. Following activation, thermolysin was inhibited with 
25 m m EDTA. The concentration of mature KLK14 was determined 
by active site titration using 4-methylumbelliferyl- p -guanidinobenzo-
ate hydrochloride (Sigma-Aldrich, Sydney, Australia). 
 Synthesis of peptide substrate libraries 
 Peptide pNA substrates were synthesized on  para -phenylenediamine 
(Sigma-Aldrich) derivatized 2-chlorotrityl resin (0.13 mmol/g) using 
fl uorenylmethyl carbamate (Fmoc)-protected amino acids (Abbenante 
et al. , 2000 ). Specifi c conditions for coupling, deprotection, cleavage 
from the solid support, oxidation of the pNA reporter, and removal of 
side-chain-protecting groups have been previously described elsewhere 
(Abbenante et al. , 2000 ; Swedberg et al. , 2009 ; Swedberg and Harris , 
2011 ). Individually synthesized substrates were assembled by sequen-
tial coupling reactions using four equivalents Fmoc-protected amino 
acids. For the P1-P4 diverse combinatorial library, fi xed positions were 
coupled as above while degenerate positions were added using a two-
step limited loading approach to compensate for the widely varying and 
context-dependent reaction rates of individual amino acids (Ragnarsson 
et al. , 1971, 1974 ; Mutter , 1979 ; Boutin et al. , 1997 ). These positions 
were fi rst coupled using an equimolar mixture of all amino acids total-
ing the molar loading capacity of the resin followed by a second round 
of coupling with four equivalents mixed amino acids to ensure oc-
cupancy at all available sites. Substrates for Michaelis-Menten kinetic 
analysis were purifi ed by reverse-phase high-performance liquid chro-
matography (rp-HPLC) using a Jupiter 4 μ Proteo 90A C-18 column 
(Phenomenex, Sydney, Australia) across a gradient of 10 % – 100 % iso-
propanol containing 0.1 % TFA. This was followed by MALDI-TOF/
MS analysis for purity and mass validation using a Biorad ProteinChip 
System: Personal Edition (Biorad, Sydney, Australia). 
 PS-SCL and sparse matrix library assays 
 Kinetic assays were carried out in 96-well transparent low-binding 
plates (Corning, Lowell, MA) using 0.1  m Tris-HCl pH 8.0, 0.1  m 
NaCl, 25 m m EDTA, 0.005 % Triton X-100 assay buffer (fi nal vol-
ume 250  μ l). Activity was detected by the change in absorbance at 405 
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nm with linear rates measured for 7 min (10 s reading interval) using 
a Biorad Benchmark Plus multi-well spectrophotometer. All data are 
shown as the mean rate ± SEM from three independent assays carried out 
in triplicate. Substrate pools for positional scanning were solubilized 
in 50 % isopropanol at 3.75 m m (by pool average molecular weight). 
Assays were performed using 7.5 n m KLK14 and approximately 
150  μ m pooled substrate per well. For the sparse matrix substrate 
screen, individually synthesized peptides were solubilized in 40 % iso-
propanol and adjusted to apparent equal molarity by total hydrolysis of 
the pNA moiety (Swedberg et al. , 2009 ). Library analysis was carried 
out using 5 n m KLK14 and approximately 250  μ m substrate per well. 
 Determination of Michaelis ( K M ) and rate ( k cat ) 
constants 
 Highly favored substrates from the sparse matrix library (YAVR, 
WAVR, YASR, WASR, YANR), independent PS-SCL screens 
(YAAR: Borgono et al. , 2007a ; WVSR: this study) and phage dis-
play (VGSLR: Felber et al. , 2005 ) were synthesized and purifi ed by 
rp-HPLC. Assays were carried out at room temperature (298 K) in 
250  μ l buffer (as above) using a constant concentration of 700 p m 
KLK14 and serial dilutions of purifi ed substrates (600 – 18.75  μ m ). 
Initial rates were measured by the change in absorbance (405 nm) 
for 7 min over three independent assays carried out in triplicate. 
Kinetic constants ( K M ,  k cat ) were determined by nonlinear regression 
in GraphPad Prism 5 (GraphPad Software) and are reported ± SEM, 
whereas  k 
cat / K M is given ± 95 % confi dence interval from the calcu-
lated propagation of error. 
 MD simulations of KLK14 substrate complexes 
 As a KLK14 structure is currently not available, a homology model 
was produced in Swiss model (Guex et al. , 2009 ) based on the KLK 
structure with the highest sequence similarity to KLK14 (KLK5: 
PDB ID 2PSX, 50 % homology). KLK14 substrates were positioned 
at the active site by overlay with the KLK5/leupeptin complex 
(C α RMSD 0.39  Å ) using SPBDV v4.1 (Guex et al. , 2009 ). 
All subsequent molecular modeling manipulations were carried 
using YASARA Dynamics v10.7.8 (Krieger et al. , 2002 ) and the 
AMBER03 force fi eld (Duan et al. , 2003 ). KLK14/substrate com-
plexes were solvated with TIP3P water (pH 8.0) and neutralized by 
Na  +  /Cl - counter ions to a fi nal concentration of 100 m m (approxi-
mating the conditions of kinetic assays), generating a system of ap-
proximately 35,000 atoms, which included 10,000 water molecules. 
For long-range electrostatics, the particle mesh Ewald algorithm was 
used with nonbonded interactions truncated at 10.5  Å . Solvated com-
plexes were subjected to conjugate gradient minimization before 500 
ps MDs while applying fi xed C α atoms. This was followed by 1 ns 
production simulations without constraints from which the average 
simulation structure was determined. Molecular surfaces were cre-
ated using CCP4MG (Potterton et al. , 2004 ) and color-coded accord-
ing to electrostatic potential (calculated by the Poisson-Boltzmann 
solver within CCP4MG using a 1.4  Å probe radius) or sequence 
conservation. 
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